期刊文献+

低剂量氨磺必利对恢复期精神分裂症患者社会功能的影响 被引量:2

The influernce of low-dose amisulpride on social function in patients with convalescent schizophrenia
下载PDF
导出
摘要 目的探讨低剂量氨磺必利对恢复期精神分裂症患者社会功能的影响。方法将60例恢复期精神分裂症患者随机分为氨磺必利组和利培酮组。利培酮组维持利培酮治疗,氨磺必利组在利培酮治疗的基础上加用低剂量氨磺必利,比较治疗前、治疗8周末两组的阳性与阴性症状量表(PANSS)、社会功能缺陷筛查量表(SDSS)和副反应量表(TESS)评分。结果治疗8周末,氨磺必利组的PANSS总分及阴性症状评分低于利培酮组,差异有统计学意义(P<0.01);SDSS各条目中总分及职业和工作、家庭外社会活动、对外界的兴趣和关心、责任心和计划性评分低于利培酮组,差异有统计学意义(P<0.05);两组TESS评分差异无统计学意义(P>0.05)。结论低剂量氨磺秘利能有效改善恢复期精神分裂症患者的阴性症状及社会功能。 Objective To investigate the influernce of low-dose amisulpride on social function in patients with convalescent schizophrenia. Methods Sixty cases of patients with convalescent schizophrenia were randomly divided into amisulpride group(n=30) and risperdal group(n=30).Only risperdal was given to the risperdal group,the amisulpride group were given with risperdal combined with low-dose amisulpride.The clinical effect of two groups were assessed with the positive and negative symptoms scale(PANSS),social disability screening schedule(SDSS) and treatment emer gent symptom scale(TESS) before treatment and at the end of the 8thweek treatment. Results At the end of the 8-week treatment,the scores of PANSS and negative symptom scale in amisulpride group were lower than those of risperdal group,the difference was significant(P〈0.01).In SDSS results,the entries of the total score and occupation,the interest and concern to outside,responsibility and planning in amisulpride group were lower than those of risperdal group,the difference was significant(P〈0.05).The TESS scores of two groups had no significant difference(P〈0.05). Conclusion Low-dose amisulpride can effectively improve the social functions and negative symptom of convalescent schizophrenia patients.
作者 申璎 陈宪生
出处 《中国当代医药》 2014年第20期53-55,共3页 China Modern Medicine
关键词 低剂量氨磺必利 恢复期精神分裂症 社会功能 Low-dose amisulpride Convalescent schizophrenia Social function
  • 相关文献

参考文献11

二级参考文献63

  • 1刘俊彪,吴靖华.氯丙嗪、氯氮平、利培酮对首发精神分裂症患者糖代谢、血脂和体重的影响[J].中国神经精神疾病杂志,2004,30(4):293-295. 被引量:41
  • 2Farde L, Wiesel FA, Halldin C, et al. Central D2 dopamine receptor occupancy in schizophrenic patients treated with anti psychotic drugs[J]. Arch Gen Psychiatry, 1988,45 (1) : 71 - 76.
  • 3Kapur S,Zipursky R,Jones C,et al. Relationship between do pamine D2 occupancy, clinical response, and side effects: a double--blind PET study of first episode schizophrenia[J]. Am J Psychiatry,2000,157(4) :514-520.
  • 4Sanofi--Aventis. Summary of product characteristics. Solian [J]. Available at: http://emc, medicines, org. uk/2008 (ac- cessed on 17 March 2009).
  • 5Puech A,Fleurot O,Rein W. Amisulpride and atypical antip sychotic,in the treatment of acute episodes of schizophrenia: a dose--ranging study vs. haloperidol. The Amisulpride Study Group[J]. Acta Psychiatr Scand, 1998,98(1) :65-72.
  • 6Stefan Leucht, Caroline Corves, Dieter Arbter. Second-- gener ation versus first--generation antipsychotic drugs for sehizo phrenia: a meta-analysis[J]. Lancet,2009,373:31-41.
  • 7Danion JM, Rein W, Fleurot O. Improvement of schizophrenic patients with primary negative symptoms treated with amisul- pride. Amisulpride Study Group[J]. Am J Psychiatry, 1999, 156(4) :610-616.
  • 8Deeks ED,Keating GM. Olanzapine/fluoxetine: a review of its use in the treatment of acute bipolar depression[J]. Drugs, 2008,68(8):1 115-1 137.
  • 9Mortimer AM, Joyce E, Balasubramaniam K, et al. Treatment with amisulpride and olanzapine improve neuropsyehologicalfunction in schizophrenia[J]. Hum Psychopharmacol, 2007,22 (7) :445-454.
  • 10Lecrubier Y, Boyer P, Turjanski S, et al. Amisulpride versus imipramine and placebo in dyslhymia and major depression. Amisulpride Study Group[J]. J Affect Disord, 1997,43(2): 95-103.

共引文献1023

同被引文献27

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部